SCHEMBL2344934

SCHEMBL2344934

CC(C)(C)OC(=O)N(Cc1ccccc1)Cc1nc(-c2ccc(-c3ccccc3)c(C(CC(N)c3nc(-c4ccc(-c5ccccc5)cc4)c[nH]3)c3ccccc3)c2)c[nH]1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 5/20 0.35
AGTR1 P30556 1/20 0.35
AGTR2 P50052 1/20 0.35
HDAC3 O15379 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC2 Q92769 1/20 0.34
NCOR2 Q9Y618 1/20 0.34
ALDH1A1 P00352 2/20 0.32
HCRTR1 O43613 1/20 0.32
FNTA P49354 1/20 0.31
FNTB P49356 1/20 0.31
MAPT P10636 2/20 0.30
NPSR1 Q6W5P4 2/20 0.30
POLB P06746 1/20 0.30
RECQL P46063 1/20 0.30
PAX8 Q06710 1/20 0.30
ROCK2 O75116 1/20 0.30
ROCK1 Q13464 1/20 0.30
CTSL P07711 1/20 0.30
CTSB P07858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1928525 0.83 HDAC3 (0.45) BACE1AGTR1AGTR2HDAC3HDAC1
SCHEMBL3615871 0.73 HDAC3 (0.42) BACE1AGTR1AGTR2HDAC3HDAC1
SCHEMBL1929153 0.71 HTR2C (0.42) HCRTR1PAX8
SCHEMBL2347049 0.68 NPSR1 (0.37) ALDH1A1MAPTNPSR1POLBPAX8
SCHEMBL19812532 0.68 P2RY12 (0.40) MAPTPOLB
SCHEMBL18730955 0.65 SSTR4 (0.34) ALDH1A1PAX8
SCHEMBL18902072 0.65 PAX8 (0.30) PAX8
SCHEMBL18731533 0.64 SSTR4 (0.39) AGTR1AGTR2HDAC3HDAC1HDAC2
SCHEMBL1925923 0.64 CTSK (0.48) ALDH1A1MAPTCTSLCTSBCTSS
SCHEMBL6812673 0.64 CACNA1G (0.42) ALDH1A1MAPTPAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1228760-B1 5-membered heterocycle derivatives, production thereof and use thereof as medicaments IPSEN PHARMA (FR) 2011-08-31 EP claimed